8-K: Sleep Number Reports 19.7% Sales Decline in Q2 2025 Amid Turnaround Efforts

Sleep Number Corporation announced a 19.7% decline in second-quarter 2025 net sales to $328 million, alongside a net loss of $25 million, as it implements significant cost savings and strategic business changes.

Summary

• Net sales for the second quarter of 2025 were $328 million, representing a 19.7% decrease compared to the second quarter of 2024.
• Gross profit margin remained flat at 59.1% compared to the prior year.
• Operating expenses were reduced by $48 million, or 21%, year-over-year, before restructuring and other non-recurring costs.
• A net loss of $25 million was reported, which includes a $13 million adjustment to the valuation of deferred tax assets, compared to a net loss of $5 million for the same period last year.
• Adjusted EBITDA was $24 million, down 17% versus the prior year.
• The company is implementing $130 million of cost savings for 2025, exceeding its prior annualized target of $80 million to $100 million, before restructuring and other non-recurring costs.
• Compliance with debt covenants is maintained, with a leverage ratio of 4.56x EBITDAR on a trailing 12-month basis against a covenant maximum of 4.75x.
• Net cash provided by operating activities was $1.2 million for the quarter, a decrease of $22 million year-over-year.
• Free cash flow was a use of $6.9 million for the quarter, down $16 million year-over-year.
• Full year 2025 net sales are expected to be approximately $1.45 billion, representing an approximately 14% year-over-year decline.
• Full year gross profit margin is expected to be 61%, consistent with the first quarter of 2025.
• Full year operating expenses, excluding restructuring and other non-recurring costs, are expected to be approximately $830 million.
• The company expects to achieve break-even free cash flow in the second half of 2025.

Sentiment

Score: 4

Explanation: While the company is taking aggressive steps to cut costs and is maintaining debt covenant compliance, the significant decline in sales (19.7%) and a larger net loss ($25 million vs. $5 million prior year) indicate a challenging financial situation. The 'turnaround' phase suggests ongoing difficulties, despite management's optimism about future sequential improvement and cost savings. The outlook for a 14% full-year sales decline is also negative.

Positives

• Gross profit margin remained consistent at 59.1% despite lower sales volume.
• Operating expenses were significantly reduced by $48 million, or 21%, year-over-year, before restructuring and non-recurring costs.
• The company is implementing $130 million in cost savings for 2025, surpassing its previous target of $80 million to $100 million.
• Compliance with debt covenants is maintained, with a leverage ratio of 4.56x EBITDAR well within the 4.75x maximum.
• The new leadership team is actively focused on enhancing product assortment, value proposition, and consumer engagement to drive future profitable growth.
• A new, more efficient marketing program is being rebuilt, with early signs indicating its effectiveness.
• Management anticipates sequential topline improvement in the coming quarters.
• Adjusted EBITDA margin improved by 30 basis points to 7.2%.

Negatives

• Net sales declined significantly by 19.7% year-over-year to $328 million.
• The company reported a net loss of $25 million, a substantial increase from the $5 million net loss in the prior year, partly due to a $13 million deferred tax asset valuation adjustment.
• Adjusted EBITDA decreased by 17% year-over-year to $24 million.
• Net cash provided by operating activities fell by $22 million year-over-year to $1.2 million.
• Free cash flow was a negative $6.9 million, a $16 million decline from the prior year.
• The full year 2025 net sales outlook projects an approximately 14% year-over-year decline to $1.45 billion.
• The company explicitly states it is in a 'turnaround' phase, indicating current operational challenges.
• Dramatic cuts in marketing spend in Q2 led to an expected sharp drop in sales.
• The topline remains pressured, despite cost management efforts.
• A reduced store count contributed to lower sales volume.
• Net loss per diluted share worsened to $(1.09) from $(0.22) in the prior year.
• The leverage ratio increased to 4.56x from 4.35x year-over-year.

Risks

• Future plans, events, financial results, or performance are subject to certain risks and uncertainties which could cause the company's results to differ materially.
• The most important risks and uncertainties are described in the company's filings with the Securities and Exchange Commission, including in Item 1A of the company's Annual Report on Form 10-K and other periodic reports.

Future Outlook

The company expects full year 2025 net sales to be approximately $1.45 billion, representing an approximately 14% year-over-year decline, partly driven by softer year-over-year comparisons and the 53rd week in 2025. Gross profit margin is expected to be 61%, consistent with the first quarter of 2025, and full year operating expenses (excluding restructuring and other non-recurring costs) are expected to be approximately $830 million. Management anticipates break-even free cash flow in the second half of 2025 and expects actions to drive sequential topline improvement in the coming quarters while aggressively managing costs.

Management Comments

• "Sleep Number is in a turnaround. I joined because it is fundamentally a great company and I continue to believe that." Linda Findley, President and CEO.
• "In my first 100 days, the new leadership team has been focused on digging into our product and consumer proposition. It is clear Sleep Number has a strong brand and differentiated products." Linda Findley.
• "We are building on these core strengths with plans to return to profitable growth by starting to implement initiatives focused on enhancing our product assortment, value proposition, and consumer engagement." Linda Findley.
• "At the start of the second quarter, we aggressively reduced expenses to reset our cost structure, and ensure ongoing compliance with our debt covenants." Linda Findley.
• "We cut marketing spend dramatically in Q2 because the old marketing strategy was inefficient, and we needed to implement a major reset. We expected the sharp drop in second quarter sales based on these changes." Linda Findley.
• "We are rebuilding this program and are already seeing signs that our new, more efficient approach is working." Linda Findley.
• "In parallel, we are also working to optimize our product portfolio, value and distribution, with the goal of focusing on the products, price points and benefits that matter most to our customers." Linda Findley.
• "We are energized by the work ahead and have created the right environment, with the right team, for Sleep Number to thrive. We have proven our ability to manage costs and improve efficiency." Linda Findley.
• "Although our topline remains pressured, we expect our actions to drive sequential topline improvement in the coming quarters while we continue to aggressively manage our costs." Linda Findley.

Industry Context

The filing focuses internally on Sleep Number's turnaround efforts, significant cost restructuring, and new marketing and product initiatives. It does not explicitly discuss broader industry trends or competitor performance, but the substantial sales decline suggests the company is navigating a challenging market or addressing company-specific underperformance relative to its potential or the broader industry.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results for industry benchmarking.

Management Changes

Stakeholder Impact

• Shareholders are facing a significant sales decline, increased net loss, and a company in 'turnaround' mode, which could impact share value. However, cost savings and strategic initiatives aim to return to profitable growth.
• Employees may be impacted by 'aggressively reduced expenses to reset our cost structure,' which could include workforce adjustments, though not explicitly stated. The company has 3,400 mission-driven team members.
• Customers are targeted with new product initiatives, enhanced value proposition, and optimized product portfolio, aiming to improve engagement and satisfaction.
• Creditors benefit from the company maintaining compliance with its debt covenants.
• Suppliers may experience an impact from reduced sales volume and cost-cutting measures.

Next Steps

• Implement initiatives focused on enhancing product assortment, value proposition, and consumer engagement to return to profitable growth.
• Rebuild the marketing program with a new, more efficient approach.
• Optimize product portfolio, value, and distribution, focusing on customer-centric products, price points, and benefits.
• Continue to aggressively manage costs.
• Drive sequential topline improvement in the coming quarters.
• Achieve break-even free cash flow in the second half of 2025.

Key Dates

Recommendation

The company is undergoing a significant turnaround with a new CEO and aggressive cost-cutting measures, which are positive steps towards stabilizing the business. However, the substantial decline in sales and increased net loss indicate ongoing challenges. While management expects sequential topline improvement and break-even free cash flow in the second half of 2025, the full-year outlook remains negative. An investor should hold to observe if the new strategies yield tangible improvements in sales and profitability in the coming quarters, as the current financial performance does not yet support a 'buy' recommendation, but the proactive management actions mitigate a 'sell' recommendation.

Keywords

Sleep Number, SNBR, bedding, smart bed, mattress, sleep wellness, financial results, Q2 2025, earnings, cost savings, turnaround, retail, consumer goods, home furnishings